- PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel. Yang, L., Clarke, M.J., Carlson, B.L., Mladek, A.C., Schroeder, M.A., Decker, P., Wu, W., Kitange, G.J., Grogan, P.T., Goble, J.M., Uhm, J., Galanis, E., Giannini, C., Lane, H.A., James, C.D., Sarkaria, J.N. Clin. Cancer Res. (2008)